Biotricity, Inc.
BTCY
$0.25
$0.00-1.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.45M | 15.08M | 14.46M | 13.79M | 13.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.45M | 15.08M | 14.46M | 13.79M | 13.27M |
| Cost of Revenue | 2.92M | 3.04M | 3.14M | 3.23M | 3.41M |
| Gross Profit | 12.53M | 12.04M | 11.32M | 10.56M | 9.86M |
| SG&A Expenses | 9.89M | 10.09M | 10.03M | 10.86M | 12.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.31M | 15.55M | 15.51M | 16.24M | 17.90M |
| Operating Income | 141.10K | -468.80K | -1.05M | -2.45M | -4.64M |
| Income Before Tax | -4.02M | -4.53M | -5.40M | -8.42M | -10.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.02 | -4.53 | -5.40 | -8.42 | -10.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.02M | -4.53M | -5.40M | -8.42M | -10.67M |
| EBIT | 141.10K | -468.80K | -1.05M | -2.45M | -4.64M |
| EBITDA | 147.10K | -462.80K | -1.04M | -2.44M | -4.63M |
| EPS Basic | -0.18 | -0.19 | -0.23 | -0.70 | -1.08 |
| Normalized Basic EPS | -0.10 | -0.11 | -0.14 | -0.27 | -0.50 |
| EPS Diluted | -0.18 | -0.19 | -0.23 | -0.70 | -1.08 |
| Normalized Diluted EPS | -0.10 | -0.11 | -0.14 | -0.27 | -0.50 |
| Average Basic Shares Outstanding | 106.99M | 103.63M | 99.36M | 87.25M | 70.33M |
| Average Diluted Shares Outstanding | 106.99M | 103.63M | 99.36M | 87.25M | 70.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.60% | -0.53% | -0.44% | -0.36% | -0.22% |